The Biomedical Advanced Research and Development Authority (BARDA) is seeking contractors to support its Pandemic Influenza Preparedness and Response Program. This involves producing vaccines, antigens, and adjuvants for pandemic preparedness and response, as well as improving existing influenza vaccines. Offerors must demonstrate experience in manufacturing influenza vaccines, either by holding a U.S. license or by having submitted a Biologics License Application (BLA).
Line Items
Item
Qty
Unit
Est. Unit Price
Est. Total
Category
Development and Manufacturing of Pandemic Influenza Vaccines
1
program
$500,000,000.00
$500,000,000.00
Medical
Development and Manufacturing of Antigens for Pandemic Preparedness
1
program
$250,000,000.00
$250,000,000.00
Medical
Development and Manufacturing of Adjuvants for Pandemic Preparedness
1
program
$250,000,000.00
$250,000,000.00
Medical
Regulatory Support and Data Generation for FDA Submissions (analytical, nonclinical, clinical, CMC)
1
program
$300,000,000.00
$300,000,000.00
Professional Services
Production of Antigen and Vaccines against Influenza Virus or other Viruses with Pandemic Potential
1
program
$200,000,000.00
$200,000,000.00
Medical
Estimated Bid Value
$1,500,000,000.00
Want the full details?
Sign up free to see the agency name and the original bid posting link, plus the 26 documents, contracting-officer contacts and AI response outlines. Every feature is free through December 31, 2026.